BioSpace News Archive

Business

Biotech Leadership Transformations for July 2

With the end of June, numerous biotechs shored up their boards of directors and other advisory boards with new members as the companies continued to shape their future strategies.

July 1, 2018
·
4 min read
·
Alex Keown
Business

Court Rules AbbVie and Besins Healthcare Must Pay $448 Million in AndroGel Antitrust Case

U.S. District Judge in Philadelphia came down on the side of the Federal Trade Commission (FTC) in an anti-trust lawsuit filed in 2014 against AbbVie and its partner Besins Healthcare. They are ordered to pay $448 million.

July 1, 2018
·
3 min read
·
Mark Terry
BioCapital

Artificial Organs for Biopharma Research and More

There has been recent coverage of 3D bioprinting and how it has the potential to create a brave new world of printed organs to be used in biopharma research and maybe someday to even be used in organ transplants.

July 1, 2018
·
4 min read
·
Mark Terry
New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation

Masimo announced the findings of a study in which researchers evaluated the ability of Masimo ORi™ (Oxygen Reserve Index) to detect declining blood oxygenation prior to standard oxygen saturation (SpO2) monitoring in patients undergoing elective thoracic surgery requiring one-lung ventilation (OLV).

July 1, 2018
·
7 min read
Yaron Eshel, Life Science Director for iCAN: Israel-Cannabis to Attend International Cannabinoid Research Society Conference in Leiden, the Netherlands July 1-4

Yaron Eshel, Director of Life Sciences for iCAN: Israel-Cannabis will attend the International Cannabinoid Research Society conference, to be held in Leiden, the Netherlands July 1st - 4th 2018. He will be available for one on one meetings.

July 1, 2018
·
1 min read
Business

NinePoint Medical Appoints Eman Namati, Ph.D., to Chief Executive Officer

NinePoint Medical, Inc. is pleased to announce the appointment of Eman Namati, Ph.D., to President and Chief Executive Officer.

July 1, 2018
·
4 min read
BioMidwest

MIVI Neuroscience Expands European Commercialization Network After Achieving CE Mark Approval Of The R4Q Revascularization Catheter For Ischemic Stroke

MIVI Neuroscience, Inc. announced the expansion of its European commercialization network with the commitment from AngioNautix of Madrid, Spain, to be its partner in Spain, Portugal and Cuba.

July 1, 2018
·
1 min read
Business

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases

Alteogen Inc. and Lynkogen Inc. announced that they have entered into an exclusive option agreement for the development of Alteogen’s novel GLP-1 mimetic and Alpha-1 Antitrypsin (A1AT) fusion proteins based on their proprietary NexPTM fusion technology to tackle NASH and metabolic diseases.

July 1, 2018
·
2 min read